Hop On A Cure Backs ALS Research At Houston Methodist To Find Cure

In a significant move towards combating amyotrophic lateral sclerosis (ALS), Hop On A Cure has announced its latest contribution to support groundbreaking research at Houston Methodist. Under the guidance of Dr. Stanley H. Appel, this initiative focuses on pioneering treatments for ALS and other neurological disorders. The research, centered at the Ann Kimball & John W. Johnson Center for Cellular Therapeutics (JCCT), aims to utilize regulatory T Cells and exosomes to mitigate inflammation within cells, a key factor in the progression of ALS.

Founded in 2022 by John Driskell Hopkins, a multi-GRAMMY® Award-winning founding member of Zac Brown Band, and his wife Jennifer following Hopkins' own ALS diagnosis in 2021, Hop On A Cure has been at the forefront of raising awareness and funding for ALS research. The foundation's commitment is driven by the urgent need for effective treatments for ALS, a disease that remains incurable.

Dr. Appel, a leading figure in neurology and ALS research, has dedicated over four decades to understanding and treating neurological disorders. His work at the Houston Methodist Neurological Institute's MDA/ALSA ALS Research and Clinical Center has been instrumental in advancing patient care and research since its establishment in 1982. This center stands as the first multidisciplinary clinic in the U.S. focused on ALS.

David Hopkins, vice president of community investments for Hop On A Cure, expressed optimism about the impact of their support on ALS research. "The research being done at Houston Methodist and the progress made during Dr. Appel’s tenure has contributed to getting us closer to finding a cure for ALS," he stated.

Hop On A Cure's mission extends beyond funding research; it aims to increase ALS awareness, foster a supportive community, and inspire hope among those affected by the disease. Despite being one of the most underfunded diseases in terms of research, Hop On A Cure is determined to make significant strides in the fight against ALS, honoring the legacy of those like Lou Gehrig who have battled the disease.

For more details on Houston Methodist's innovative research and programs dedicated to ALS treatment and care, interested parties are encouraged to seek further information.

This collaboration between Hop On A Cure and Houston Methodist represents a beacon of hope for individuals affected by ALS. Through their combined efforts, they aim to accelerate the development of new treatments that could potentially lead to a cure for this devastating disease.